Study of Dietary Patterns and Food Diversity in Russian GERD Patients
1 other identifier
interventional
150
1 country
1
Brief Summary
The aim of the study is to assess food diversity and dietary patterns in Russian GERD patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2020
CompletedFirst Submitted
Initial submission to the registry
January 31, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFebruary 3, 2022
February 1, 2022
3.7 years
January 31, 2020
February 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
grains consumption diversity
Mean number of different types of grains consumed in form of different foods or food products a month during 12-months period
a month
meat consumption diversity
Mean number of different types of meat consumed in form of different foods or food products a month during 12-months period
a month
poultry consumption diversity
Mean number of different types of poultry consumed in form of different foods or food products a month during 12-months period
a month
fish consumption diversity
Mean number of different types of fish consumed in form of different foods or food products a month during 12-months period
a month
flour consumption diversity
Mean number of different types of flours consumed in form of different foods or food products a month during 12-months period
a month
vegetables consumption diversity
Mean number of different types of vegetables consumed as is or in the form of different foods or food products
a month
Fruits consumption diversity
Mean number of different types of fruits consumed as is or in the form of different foods or food products
a month
Fats consumption diversity
Mean number of different types of fats consumed in the form of different foods or food products a month by 12 month period
a month
Secondary Outcomes (1)
GERD-associated dietary pattern
a year
Study Arms (2)
GERD
EXPERIMENTALPatients with verified gastroesophageal reflux disease
Contol
OTHERMostly healthy subjects who have no symptoms and other manifestations of gastroesophageal reflux disease by complex examination
Interventions
Dietary assessment is not within standards of care for patients with gastroesophageal reflux disease in Russia. Subjects enrolled to the study are to be interviewed on most common foods consumption in terms of frequency of use and sizes of portions.
Eligibility Criteria
You may qualify if:
- willingness to participate (signed the informed consent form);
- willingness to follow all the required procedures;
You may not qualify if:
- Pregnant or breast-feeding females;
- Neoplasms, current or by the medical history (except local skin cancer successfully treated);
- History of chest or abdominal surgery, except appendectomy and cholecistectomy (in case when no consequences of these operations like adhesive disease of the abdominal cavity are present);
- Co-morbid conditions which can influence or mask the symptoms of GERD (including, but not limited to: ischaemic heart disease, severe pulmonary disease, severe depression or anxiety, etc);
- the use of concomitant medications that may influence on the symptoms or other manifestations of gastroesophageal reflux disease: NSAIDs, corticosteroids (except topic ones for no longer than 2 weeks), any medications directly influencing mood and function of central nervous system (antidepressants, anxiolytics, anti-anxiety agents, anticonvulsant etc) at the moment of enrolment and during a 2 half-life period of the certain drug;
- the use of medications that influence gastric secretion at the time of enrolment and during 2 week before it;
- any condition of the patient which makes the participation of the patient in the study unreasonable or put him at risk of the condition's exacerbation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Russian Academy of Medical Scienceslead
- Russian Science Foundationcollaborator
Study Sites (1)
Gastroenterology and Hepatology, FRC Nutrition and Biotechnology
Moscow, 115446, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Vasily Isakov, MD, PhD, Professor, AGAF
FRC nutrition and biotechnology
- PRINCIPAL INVESTIGATOR
Sergey Morozov, MD, PhD
FRC Nutrition and Biotechnology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Professor, AGAF
Study Record Dates
First Submitted
January 31, 2020
First Posted
February 5, 2020
Study Start
January 30, 2020
Primary Completion
September 30, 2023
Study Completion
December 31, 2023
Last Updated
February 3, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- After the study completion, available for 2 years
- Access Criteria
- By request
Study data may be shared by request after study completion, except subjects' personal (identification) information